Sput­nik 2.0? Chi­nese re­search team first to try CRISPR-Cas9 gene-edit­ing tech on a hu­man

Call it a CRISPR-Cas9 gap.

A lit­tle more than two weeks ago Chi­nese in­ves­ti­ga­tors de­liv­ered genes edit­ed with CRISPR-Cas9 tech in­to a lung can­cer pa­tient as part of a clin­i­cal tri­al, re­ports Na­ture. It was the first use of CRISPR-Cas9 in hu­mans, beat­ing out Carl June at the Uni­ver­si­ty of Penn­syl­va­nia by sev­er­al months.

And June — who helped pi­o­neer CAR-T tech in a show­down with ri­vals like Juno and Kite — sees a du­el de­vel­op­ing be­tween East and West. And that’s not nec­es­sar­i­ly a bad thing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.